Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Abou Chakra, M"'
Autor:
Azoulai, D., Boustany, J., Peyromaure, M., Abou Chakra, M., Duquesne, I., Barry Delongchamps, N.
Publikováno v:
In Progrès en Urologie December 2022 32(16):1469-1475
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 15, Pp 453-462 (2021)
Mohamad Moussa,1 Athanasios Papatsoris,2 Mohamed Abou Chakra,1 Athanasios Dellis2,3 1Department of Urology, Al Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon; 2 2nd Department of Urology, School of Medicine, Sismanog
Externí odkaz:
https://doaj.org/article/eb402292e82b4096a99be7b8a856faf2
Autor:
Bailly, H, Abou Chakra, M, Schill, F, Dabboucy, B, Khalil, C, Lorenz, M, Rodehutskors, N, Boaz, J, Jida, M, El Beayni, N, Ismail, K, Hanna, E, Hage, L, Abo Yassine, A, Delavar, G, Popescu, A, Moussa, M
Publikováno v:
In Continence September 2023 7 Supplement 1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moussa, M, Dabboucy, B, Papatsoris, A, Moussa, Y, Fares, Y, Dellis, A, Issa, H, Bailly, H, Abou Chakra, M
Publikováno v:
In Continence June 2022 2 Supplement 2
Introduction: Currently, in prostate cancer, an increasing number of novel drugs are being used to delay its advancement to metastatic castration-resistant prostate cancer (mCRPC). Apalutamide, enzalutamide, and most recently, darolutamide (novel and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0ca8e28b3b3e1033a48cc6897f7342c0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020586
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020586
Introduction: Metastatic castration-resistant prostate cancer (CRPC) is a potentially symptomatic disease with an eventual lethal outcome. Novel pharmaceutical agents are continuously studied with encouraging results in CRPC. Areas covered: In this p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4a17bd28ff205ab6a4516d0e2b5604ba
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020770
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020770
Introduction: Treatment of recurrent Urinary tract infections (UTIs) has become challenging because of the dramatic increase in the rates of recurrent infection andof multidrug-resistant (MDR) infections. Areas covered: The authors review recurrent U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::60d8ed381d050acd2feb5d202d5adcb2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3021027
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3021027
Introduction: Many patients with non-muscle-invasive bladder cancer (NMIBC) failed intravesical BCG therapy. Currently, radical cystectomy is the recommended standard of care for those patients. There is unfortunately no effective other second-line t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5bcdc8867bd28ba95d051dacb270fbb8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120558
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120558